A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy

Author(s):
Bot, I. (0000-0002-1242-1959); Ortiz Zacarias, N.V. (0000-0001-7470-5546); Witte, W.E. de; Vries, H. de; Santbrink, P.J. van; Velden, D. van der; Kroener, M.J.; Berg, D.J. van den; Stamos, D.; Lange, E.C.M. de (0000-0001-8303-1117); Kuiper, J.; IJzerman, A.P. (0000-0002-1182-2259); Heitman, L.H. (0000-0002-1381-8464)
Published
2017
Publication type
Article / Letter to editor
AtherosclerosisDrug discovery and development
Date issued
2017-03-03
Language
English
Is part of
Scientific Reports (2017), Vol. 2017, no. 7, p. 52
hdl
1887/49661
doi
10.1038/s41598-017-00104-z